These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17184852)

  • 1. A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b.
    Okamoto K; Akuta N; Kumada H; Kobayashi M; Matsuo Y; Tazawa H
    J Virol Methods; 2007 Apr; 141(1):1-6. PubMed ID: 17184852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Matsuda M; Kobayashi M; Arase Y; Ikeda K; Kumada H
    Intervirology; 2005; 48(6):372-80. PubMed ID: 16024941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
    Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
    J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity and response to IFN of the NS3 protease gene from clinical strains of the hepatitis C virus.
    Holland-Staley CA; Kovari LC; Golenberg EM; Pobursky KJ; Mayers DL
    Arch Virol; 2002 Jul; 147(7):1385-406. PubMed ID: 12111414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J; Czibula A; Simon J; Kalmár T
    Orv Hetil; 2003 Jun; 144(24):1179-84. PubMed ID: 12866147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.
    Seko Y; Akuta N; Suzuki F; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2013; 56(1):13-21. PubMed ID: 22907167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
    J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method to detect substitutions in the interferon-sensitivity-determining region of hepatitis C virus 1b for prediction of response to interferon therapy.
    Nishiguchi S; Ueda T; Itoh T; Enomoto M; Tanaka M; Tatsumi N; Fukuda K; Tamori A; Habu D; Takeda T; Otani S; Shiomi S
    Hepatology; 2001 Jan; 33(1):241-7. PubMed ID: 11124842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
    Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the STAT1‑interacting domain of the hepatitis C virus core protein modulate the response to antiviral therapy.
    Anjum S; Afzal MS; Ahmad T; Aslam B; Waheed Y; Shafi T; Qadri I
    Mol Med Rep; 2013 Aug; 8(2):487-92. PubMed ID: 23799612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
    Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
    J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved amplification system for detection of hepatitis C virus genome that simultaneously differentiates viral genotypes.
    Songsivilai S; Kanistanon D; Panyavinin W; Neelamek M; Dharakul T
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):237-43. PubMed ID: 9279983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
    Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
    J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    Oh HB; Kim SO; Cha CH; Hong SP; Folk WR; Kim KM; Suh DJ
    J Med Virol; 2008 Oct; 80(10):1712-9. PubMed ID: 18712825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning, sequencing and expression of core and NS3 fragments of HCV from patients with HCV infection.
    Tan DM; Hu GL; Arima T; Zhang Z; Nanba T; Hatanaka T
    Chin Med J (Engl); 1993 Jul; 106(7):522-6. PubMed ID: 8243124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.